References
- A. Kishida, JBD, Yoshioka, S., Aso, Y., Takeda, Y. (1990). Some Determinants of Morphology and Release Rate from Poly(L)Lactic Acid Microspheres. Journal of Controlled Release.13, 83–89.
- Ayan E, Kaplan MB, Koksela O, Tamer L, Karabacak T, Ayaz LOzdulger A (2008). Efficiency of Lornoxicam in Lung and Trachea Injury Caused by Peroxynitrite. Pulmonary Pharmacology and Therapeutics.21, 201–207.
- Berg J, Fellier H, Christoph T, Grarup JStimmeder D (1999). The Analgesic Nsaid Lornoxicam Inhibits Cyclooxygenase (Cox)-1/-2, Inducible Nitric Oxide Synthase (Inos), and the Formation of Interleukin (Il)-6 in Vitro. Inflammation Research.48, 369–379.
- Betre H, Liu W, Zalutsky MR, Chilkoti A, Kraus VBSetton LA (2006). A Thermally Responsive Biopolymer for Intra-Articular Drug Delivery. J Control Release.115, 175–182.
- Bigi A, Cojazzi G, Panzavolta S, Rubini KRoveri N (2001). Mechanical and Thermal Properties of Gelatin Films at Different Degrees of Glutaraldehyde Crosslinking. Biomaterials.22, 763–768.
- Ding Yue DH, Shangli Liu Ruofan, Ma (2004). The Efficacy and Safety of Lornoxicam in Treatment of Rheumatoid Arthritis and Osteoarthritis. Chinese journal of new drugs.13, 562–564.
- Draye JP, Delaey B, Van de Voorde A, Van Den Bulcke A, De Reu BSchacht E (1998). In Vitro and in Vivo Biocompatibility of Dextran Dialdehyde Cross-Linked Gelatin Hydrogel Films. Biomaterials.19, 1677–1687.
- Freitas S, Merkle HPGander B (2005). Microencapsulation by Solvent Extraction/Evaporation: Reviewing the State of the Art of Microsphere Preparation Process Technology. J Control Release.102, 313–332.
- Gerwin N, Hops CLucke A (2006). Intraarticular Drug Delivery in Osteoarthritis. Adv Drug Deliv Rev.58, 226–242.
- Gerwin N, Hops CLucke A (2006). Intraarticular Drug Delivery in Osteoarthritis. Advanced Drug Delivery Reviews.58, 226–242.
- Guo L, Liu G, Hong RYLi HZ (2010). Preparation and Characterization of Chitosan Poly(Acrylic Acid) Magnetic Microspheres. Mar Drugs.8, 2212–2222.
- H S (1997). Microencapsulation Techniques Using Ethyl Acetate as a Dispersed Solvent: Effects of Its Extraction Rate on the Characteristics of Plga Microspheres. Journal of Controlled Release.47, 233–245.
- Horisawa E, Hirota T, Kawazoe S, Yamada J, Yamamoto H, Takeuchi HKawashima Y (2002). Prolonged Anti-Inflammatory Action of Dl-Lactide/Glycolide Copolymer Nanospheres Containing Betamethasone Sodium Phosphate for an Intra-Articular Delivery System in Antigen-Induced Arthritic Rabbit. Pharm Res.19, 403–410.
- Hunter DJ, McDougall JJKeefe FJ (2008). The Symptoms of Osteoarthritis and the Genesis of Pain. Rheumatic Diseases Clinics of North America.34, 623–643.
- Inoue A, Takahashi KA, Arai Y, Tonomura H, Sakao K, Saito M, Fujioka M, Fujiwara H, Tabata YKubo T (2006). The Therapeutic Effects of Basic Fibroblast Growth Factor Contained in Gelatin Hydrogel Microspheres on Experimental Osteoarthritis in the Rabbit Knee. Arthritis and Rheumatism.54, 264–270.
- Liang LS, Jackson J, Min W, Risovic V, Wasan KMBurt HM (2004). Methotrexate Loaded Poly(L-Lactic Acid) Microspheres for Intra-Articular Delivery of Methotrexate to the Joint. J Pharm Sci.93, 943–956.
- Liang LS, Wong WBurt HM (2005). Pharmacokinetic Study of Methotrexate Following Intra-Articular Injection of Methotrexate Loaded Poly(L-Lactic Acid) Microspheres in Rabbits. J Pharm Sci.94, 1204–1215.
- M. Fransen, SM, Hernandez-Molina, G., Reichenbach, S. (2010). Does Land-Based Exercise Reduce Pain and Disability Associated with Hip Osteoarthritis? A Meta-Analysis of Randomized Controlled Trials. Osteoarthritis and Cartilage.18, 613–620.
- McGinity JWO’, Donnell PB (1997). Preparation of Microspheres by the Solvent Evaporation Technique. Adv Drug Deliv Rev.28, 25–42.
- Morita T, Sakamura Y, Horikiri Y, Suzuki TYoshino H (2000). Protein Encapsulation into Biodegradable Microspheres by a Novel S/O/W Emulsion Method Using Poly(Ethylene Glycol) as a Protein Micronization Adjuvant. Journal of Controlled Release.69, 435–444.
- Patil KR, Rane VP, Sangshetti JNShinde DB (2009). Stability-Indicating Lc Method for Analysis of Lornoxicam in the Dosage Form. Chromatographia.69, 1001–1005.
- Patil S, Babbar A, Mathur R, Mishra ASawant K (2010). Mucoadhesive Chitosan Microspheres of Carvedilol for Nasal Administration. J Drug Target.18, 321–331.
- Paulo Costa JMSL (2001). Modeling and Comparison of Dissolution Profiles. European Journal of Pharmaceutical Sciences.13 123–133.
- Pruss TP, Stroissnig H, Radhofer-Welte S, Wendtlandt W, Mehdi N, Takacs FFellier H (1990). Overview of the Pharmacological Properties, Pharmacokinetics and Animal Safety Assessment of Lornoxicam. Postgraduate Medical Journal.66 Suppl 4, S18–21
- Lawrence Reva C., Helmick, Charles G., Arnett, Frank C., (1998). Estimates of the Prevalence of Arthritis and Selected Musculoskeletal Disorders in the United States. Arthritis & Rheumatism.41, 778–799.
- Sakakibara Y, Nishimura K, Tambara K, Yamamoto M, Lu F, Tabata YKomeda M (2002). Prevascularization with Gelatin Microspheres Containing Basic Fibroblast Growth Factor Enhances the Benefits of Cardiomyocyte Transplantation. Journal of Thoracic and Cardiovascular Surgery.124, 50–56.
- Saricaoglu F, Dal D, Atilla P, Iskit AB, Tarhan O, Asan EAypar U (2008). Effect of Intraarticular Injection of Lornoxicam on the Articular Cartilage & Synovium in Rat. Indian Journal of Medical Research.127, 362–365.
- Sayre EC, Li LC, Kopec JA, Esdaile JM, Bar SCibere J (2010). The Effect of Disease Site (Knee, Hip, Hand, Foot, Lower Back or Neck) on Employment Reduction Due to Osteoarthritis. Plos One.5,.
- Sen S, Doger FK, Aydin ON, Karul ADost T (2006). The Protective Effect of Nitroglycerin on Gastrointestinal and Renal Side Effects of Lornoxicam in Rats. Eur J Pharmacol.541, 191–197.
- Shive MSAnderson JM (1997). Biodegradation and Biocompatibility of Pla and Plga Microspheres. Adv Drug Deliv Rev.28, 5–24.
- Surh J, Decker EAMcClements DJ (2006). Properties and Stability of Oil-in-Water Emulsions Stabilized by Fish Gelatin. Food Hydrocolloids.20, 596–606.
- Tabata Y, Hijikata S, Muniruzzaman MIkada Y (1999). Neovascularization Effect of Biodegradable Gelatin Microspheres Incorporating Basic Fibroblast Growth Factor. J Biomater Sci Polym Ed.10, 79–94.
- Tabata YIkada Y (1989). Synthesis of Gelatin Microspheres Containing Interferon. Pharm Res.6, 422–427.
- Tamber H, Johansen P, Merkle HPGander B (2005). Formulation Aspects of Biodegradable Polymeric Microspheres for Antigen Delivery. Adv Drug Deliv Rev.57, 357–376.
- Tsung MJBurgess DJ (2001). Preparation and Characterization of Gelatin Surface Modified Plga Microspheres. AAPS PharmSci.3, 14–24.
- Tuncay M, Calis S, Kas HS, Ercan MT, Peksoy IHincal AA (2000). In Vitro and in Vivo Evaluation of Diclofenac Sodium Loaded Albumin Microspheres. J Microencapsul.17, 145–155.
- Zhang hu Zx Li, huifan (2006). The Effects of Lornoxicam on Chronic Arthritis in Rat. yunnan medicine.27, 420–422.